Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure

Soko Setoguchi, Yoshitaka Hirooka, Kenichi Eshima, Hiroaki Shimokawa, Akira Takeshita

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Endothelium-dependent vasodilation is impaired in patients with chronic heart failure (CHF). However, the mechanisms responsible for this effect are not fully understood. The vasodilator response to acetylcholine (ACh) has been used to examine the endothelium-dependent vasodilation in humans and is known to be mediated by nitric oxide (NO). The impaired production of NO or an increase in its degradation is thought to be responsible for the endothelial dysfunction in CHF. The aim of this study was to determine whether the decrease in availability of tetrahydrobiopterin (BH4), an essential cofactor of NO synthase, contributes to the impairment of endothelium-dependent vasodilation in patients with CHF. Fourteen patients with CHF (New York Heart Association functional class II-IV, age: 59 ± 4 years, ejection fraction: 28 ± 3%) and seven age-matched control subjects were examined. Forearm blood flow (FBF) was measured by plethysmography during an intra-arterial infusion of a graded dose of ACh (4, 8, and 16 μg/min) and sodium nitroprusside (SNP) (0.8, 1.6, and 3.2 μg/min). These procedures were repeated during a co-infusion of BH4 (400 μg/min). The forearm vasodilator response to ACh was significantly enhanced during co-infusion of BH4 in patients with CHF, whereas no effect was observed in healthy subjects. In contrast, the response to SNP was not affected by BH4 in either group. The administration of BH4 did not alter the baseline FBF in either group. These results suggest that an acute administration of BH4 improves endothelium-dependent forearm vasodilation in patients with CHF.

Original languageEnglish
Pages (from-to)363-368
Number of pages6
JournalJournal of Cardiovascular Pharmacology
Volume39
Issue number3
DOIs
Publication statusPublished - Mar 7 2002

Fingerprint

Forearm
Vasodilation
Endothelium
Heart Failure
Acetylcholine
Nitroprusside
Vasodilator Agents
Nitric Oxide
Intra Arterial Infusions
Plethysmography
Nitric Oxide Synthase
sapropterin
Healthy Volunteers

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure. / Setoguchi, Soko; Hirooka, Yoshitaka; Eshima, Kenichi; Shimokawa, Hiroaki; Takeshita, Akira.

In: Journal of Cardiovascular Pharmacology, Vol. 39, No. 3, 07.03.2002, p. 363-368.

Research output: Contribution to journalArticle

Setoguchi, Soko ; Hirooka, Yoshitaka ; Eshima, Kenichi ; Shimokawa, Hiroaki ; Takeshita, Akira. / Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure. In: Journal of Cardiovascular Pharmacology. 2002 ; Vol. 39, No. 3. pp. 363-368.
@article{731d12853403494e8c4f00a0b14026b1,
title = "Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure",
abstract = "Endothelium-dependent vasodilation is impaired in patients with chronic heart failure (CHF). However, the mechanisms responsible for this effect are not fully understood. The vasodilator response to acetylcholine (ACh) has been used to examine the endothelium-dependent vasodilation in humans and is known to be mediated by nitric oxide (NO). The impaired production of NO or an increase in its degradation is thought to be responsible for the endothelial dysfunction in CHF. The aim of this study was to determine whether the decrease in availability of tetrahydrobiopterin (BH4), an essential cofactor of NO synthase, contributes to the impairment of endothelium-dependent vasodilation in patients with CHF. Fourteen patients with CHF (New York Heart Association functional class II-IV, age: 59 ± 4 years, ejection fraction: 28 ± 3{\%}) and seven age-matched control subjects were examined. Forearm blood flow (FBF) was measured by plethysmography during an intra-arterial infusion of a graded dose of ACh (4, 8, and 16 μg/min) and sodium nitroprusside (SNP) (0.8, 1.6, and 3.2 μg/min). These procedures were repeated during a co-infusion of BH4 (400 μg/min). The forearm vasodilator response to ACh was significantly enhanced during co-infusion of BH4 in patients with CHF, whereas no effect was observed in healthy subjects. In contrast, the response to SNP was not affected by BH4 in either group. The administration of BH4 did not alter the baseline FBF in either group. These results suggest that an acute administration of BH4 improves endothelium-dependent forearm vasodilation in patients with CHF.",
author = "Soko Setoguchi and Yoshitaka Hirooka and Kenichi Eshima and Hiroaki Shimokawa and Akira Takeshita",
year = "2002",
month = "3",
day = "7",
doi = "10.1097/00005344-200203000-00007",
language = "English",
volume = "39",
pages = "363--368",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure

AU - Setoguchi, Soko

AU - Hirooka, Yoshitaka

AU - Eshima, Kenichi

AU - Shimokawa, Hiroaki

AU - Takeshita, Akira

PY - 2002/3/7

Y1 - 2002/3/7

N2 - Endothelium-dependent vasodilation is impaired in patients with chronic heart failure (CHF). However, the mechanisms responsible for this effect are not fully understood. The vasodilator response to acetylcholine (ACh) has been used to examine the endothelium-dependent vasodilation in humans and is known to be mediated by nitric oxide (NO). The impaired production of NO or an increase in its degradation is thought to be responsible for the endothelial dysfunction in CHF. The aim of this study was to determine whether the decrease in availability of tetrahydrobiopterin (BH4), an essential cofactor of NO synthase, contributes to the impairment of endothelium-dependent vasodilation in patients with CHF. Fourteen patients with CHF (New York Heart Association functional class II-IV, age: 59 ± 4 years, ejection fraction: 28 ± 3%) and seven age-matched control subjects were examined. Forearm blood flow (FBF) was measured by plethysmography during an intra-arterial infusion of a graded dose of ACh (4, 8, and 16 μg/min) and sodium nitroprusside (SNP) (0.8, 1.6, and 3.2 μg/min). These procedures were repeated during a co-infusion of BH4 (400 μg/min). The forearm vasodilator response to ACh was significantly enhanced during co-infusion of BH4 in patients with CHF, whereas no effect was observed in healthy subjects. In contrast, the response to SNP was not affected by BH4 in either group. The administration of BH4 did not alter the baseline FBF in either group. These results suggest that an acute administration of BH4 improves endothelium-dependent forearm vasodilation in patients with CHF.

AB - Endothelium-dependent vasodilation is impaired in patients with chronic heart failure (CHF). However, the mechanisms responsible for this effect are not fully understood. The vasodilator response to acetylcholine (ACh) has been used to examine the endothelium-dependent vasodilation in humans and is known to be mediated by nitric oxide (NO). The impaired production of NO or an increase in its degradation is thought to be responsible for the endothelial dysfunction in CHF. The aim of this study was to determine whether the decrease in availability of tetrahydrobiopterin (BH4), an essential cofactor of NO synthase, contributes to the impairment of endothelium-dependent vasodilation in patients with CHF. Fourteen patients with CHF (New York Heart Association functional class II-IV, age: 59 ± 4 years, ejection fraction: 28 ± 3%) and seven age-matched control subjects were examined. Forearm blood flow (FBF) was measured by plethysmography during an intra-arterial infusion of a graded dose of ACh (4, 8, and 16 μg/min) and sodium nitroprusside (SNP) (0.8, 1.6, and 3.2 μg/min). These procedures were repeated during a co-infusion of BH4 (400 μg/min). The forearm vasodilator response to ACh was significantly enhanced during co-infusion of BH4 in patients with CHF, whereas no effect was observed in healthy subjects. In contrast, the response to SNP was not affected by BH4 in either group. The administration of BH4 did not alter the baseline FBF in either group. These results suggest that an acute administration of BH4 improves endothelium-dependent forearm vasodilation in patients with CHF.

UR - http://www.scopus.com/inward/record.url?scp=0036183645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036183645&partnerID=8YFLogxK

U2 - 10.1097/00005344-200203000-00007

DO - 10.1097/00005344-200203000-00007

M3 - Article

C2 - 11862115

AN - SCOPUS:0036183645

VL - 39

SP - 363

EP - 368

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 3

ER -